← Rita F. Redberg

Papers by Rita F. Redberg

Page 2 · newest first

51. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokersChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2022
52. Elastin degradation markers are elevated in never-smokers with past history of prolonged exposure to secondhand tobacco smoke and are inversely associated with their lung function2021
53. Is the FDA Failing Women?The AMA Journal of Ethic · 2021
54. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than DeathJAMA Internal Medicine · 2021
55. Medicare and the Shocking US Food and Drug Administration Approval of AducanumabJAMA Internal Medicine · 2021
56. Gender, Race, Ethnicity, and Sexual Orientation of Editors at Leading Medical and Scientific JournalsJAMA Internal Medicine · 2021
57. Equity and the JAMA NetworkJAMA · 2021
58. Equity and the JAMA NetworkJAMA Network Open · 2021
59. Equity and the JAMA NetworkJAMA Neurology · 2021
60. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference ReportCirculation · 2021
61. Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial InfarctionJAMA Network Open · 2021
62. Screening for Lipoprotein(a) Levels in Persons at Low Risk for Cardiovascular DiseaseJAMA Internal Medicine · 2021
63. Early Noninvasive Cardiac Testing After Emergency Department Evaluation for Suspected Acute Coronary SyndromeJAMA Internal Medicine · 2020
64. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAATrials · 2020
65. Automated Identification and Extraction of Exercise Treadmill Test ResultsJournal of the American Heart Association · 2020
66. Leading the Call for Reform of Medical Device Safety SurveillanceJAMA Internal Medicine · 2019
67. Moving From Substantial Equivalence to Substantial Improvement for 510(k) DevicesJAMA · 2019
68. Evaluation of technologies approved for supplemental payments in the United StatesBMJ · 2019
69. Vascular Aging Is Accelerated in Flight Attendants With Occupational Secondhand Smoke ExposureJournal of Occupational and Environmental Medicine · 2018
70. Association Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement OutcomesJAMA Cardiology · 2018
71. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authorsBMJ · 2018
72. Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review ProgramJAMA Internal Medicine · 2018
73. Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxabanPLoS ONE · 2018
74. Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery DiseaseJAMA Internal Medicine · 2017
75. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial FibrillationJournal of Managed Care & Specialty Pharmacy · 2017
76. Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device SupplementsJAMA · 2017
77. Power Morcellators, Postmarketing Surveillance, and the US Food and Drug AdministrationJAMA · 2017
78. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart AssociationCirculation · 2017
79. Statins for Primary PreventionJAMA Internal Medicine · 2016
80. Availability and Dissemination of Results From US Food and Drug Administration–Mandated Postapproval Studies for Medical DevicesJAMA Internal Medicine · 2016
81. A Review of the Relationships Between Endogenous Sex Steroids and Incident Ischemic Stroke and Coronary Heart Disease EventsCurrent Cardiology Reviews · 2015
82. The Role of Post–Acute Care in Variation in the Medicare ProgramJAMA Internal Medicine · 2015
83. Approaches to Enhancing Radiation Safety in Cardiovascular ImagingCirculation · 2014
84. Assessing the Safety and Effectiveness of Devices After US Food and Drug Administration ApprovalJAMA Internal Medicine · 2014
85. Sham Controls in Medical Device TrialsNew England Journal of Medicine · 2014
86. The trouble with dabigatranBMJ · 2014
87. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart DiseaseCirculation · 2014
88. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insuredCurrent Medical Research and Opinion · 2014
89. Will new statin guidelines lead to overtreatment?Clinical Lipidology · 2014
90. Premarket Approval Supplement Pathway: Do We Know What We Are Getting?Annals of Internal Medicine · 2014
91. Opening the FDA Black BoxJAMA · 2014
92. Antianginal Therapy Before Percutaneous Coronary InterventionCirculation Cardiovascular Interventions · 2013
93. Mortality in Medicare Patients Undergoing Elective Percutaneous Coronary Intervention With or Without Antecedent Stress TestingCirculation Cardiovascular Quality and Outcomes · 2013
94. The 510(k) Ancestry of a Metal-on-Metal Hip ImplantNew England Journal of Medicine · 2013
95. Medical Device Regulation: Time to Improve PerformancePLoS Medicine · 2012
96. Coronary CT Angiography for Acute Chest PainNew England Journal of Medicine · 2012
97. Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke ExposurePLoS ONE · 2012
98. The Archives of Internal MedicineArchives of Internal Medicine · 2012
99. Evaluating Sex Differences in Medical Device Clinical TrialsJAMA · 2012
100. Associations between respiratory illnesses and secondhand smoke exposure in flight attendants: A cross-sectional analysis of the Flight Attendant Medical Research Institute SurveyEnvironmental Health · 2011